BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1700795)

  • 1. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
    Carrera CJ; Terai C; Lotz M; Curd JG; Piro LD; Beutler E; Carson DA
    J Clin Invest; 1990 Nov; 86(5):1480-8. PubMed ID: 1700795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
    Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
    Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
    Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
    Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
    J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.
    Avery TL; Rehg JE; Lumm WC; Harwood FC; Santana VM; Blakley RL
    Cancer Res; 1989 Sep; 49(18):4972-8. PubMed ID: 2569929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells.
    Griffig J; Koob R; Blakley RL
    Cancer Res; 1989 Dec; 49(24 Pt 1):6923-8. PubMed ID: 2573423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [nhibitory effect of adenosine analogues on invasion of human ovarian cancer cell line HO-8910PM].
    Zhu F; Liu XG; Liang NC
    Ai Zheng; 2004 Dec; 23(12):1646-50. PubMed ID: 15601553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
    Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes.
    Carson DA; Carrera CJ; Wasson DB; Yamanaka H
    Adv Enzyme Regul; 1988; 27():395-404. PubMed ID: 2907967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of 2-chlorodeoxyadenosine-induced cell death.
    Wataya Y; Hirota Y; Hiramoto-Yoshioka A; Tanaka S; Otani T; Minowada J; Matsuda A; Ueda T
    Adv Exp Med Biol; 1989; 253B():227-34. PubMed ID: 2575349
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.
    Callard RE; Ewing TM; Fox RM
    Clin Exp Immunol; 1984 Oct; 58(1):136-44. PubMed ID: 6236916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inability of poly-ADP-ribosylation inhibitors to protect peripheral blood lymphocytes from the toxic effects of ADA inhibition.
    Ganeshaguru K; Piga A; Latini L; Hoffbrand AV
    Adv Exp Med Biol; 1989; 253B():251-8. PubMed ID: 2532859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma.
    Marks DI; Rockman SP; Oziemski MA; Fox RM
    J Clin Invest; 1990 Dec; 86(6):2080-5. PubMed ID: 2123891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
    Johnston JB
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors.
    Wakade AR; Przywara DA; Palmer KC; Kulkarni JS; Wakade TD
    J Biol Chem; 1995 Jul; 270(30):17986-92. PubMed ID: 7629106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by various deoxynucleosides against deoxyadenosine-induced DNA damage in adenosine deaminase-inactivated lymphocytes.
    Shimoyama RK; Seto S; Mori C
    Mol Genet Metab; 1999 Dec; 68(4):455-60. PubMed ID: 10607474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.